Q32 Bio Inc. 0T6G.L Stock
Q32 Bio Inc. Price Chart
Q32 Bio Inc. 0T6G.L Financial and Trading Overview
Q32 Bio Inc. stock price | 28.91 USD |
Previous Close | 1.1 USD |
Open | 0 USD |
Bid | 0 USD x N/A |
Ask | 0 USD x N/A |
Day's Range | 0 - 0 USD |
52 Week Range | 0 - 2.98 USD |
Volume | 45.6K USD |
Avg. Volume | 2.01K USD |
Market Cap | 396.78K USD |
Beta (5Y Monthly) | -0.072535 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.048 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0T6G.L Valuation Measures
Enterprise Value | -61337596 USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.123683915 |
Price/Book (mrq) | 0.39231354 |
Enterprise Value/Revenue | -19.12 |
Enterprise Value/EBITDA | 0.503 |
Trading Information
Q32 Bio Inc. Stock Price History
Beta (5Y Monthly) | -0.072535 |
52-Week Change | -49.21% |
S&P500 52-Week Change | 20.43% |
52 Week High | 2.98 USD |
52 Week Low | 0 USD |
50-Day Moving Average | 1.34 USD |
200-Day Moving Average | 1.48 USD |
0T6G.L Share Statistics
Avg. Volume (3 month) | 2.01K USD |
Avg. Daily Volume (10-Days) | 2.62K USD |
Shares Outstanding | 37.31M |
Float | 30.78M |
Short Ratio | N/A |
% Held by Insiders | 9.18% |
% Held by Institutions | 47.46% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -3839.58% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -30.25% |
Return on Equity (ttm) | -60.24% |
Income Statement
Revenue (ttm) | 3.21M USD |
Revenue Per Share (ttm) | 0.06 USD |
Quarterly Revenue Growth (yoy) | 0% |
Gross Profit (ttm) | -95143000 USD |
EBITDA | -122004000 USD |
Net Income Avi to Common (ttm) | -125954000 USD |
Diluted EPS (ttm) | -0.048 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 150.02M USD |
Total Cash Per Share (mrq) | 2.6 USD |
Total Debt (mrq) | 29.1M USD |
Total Debt/Equity (mrq) | 19.16 USD |
Current Ratio (mrq) | 8.299 |
Book Value Per Share (mrq) | 2.628 |
Cash Flow Statement
Operating Cash Flow (ttm) | -109031000 USD |
Levered Free Cash Flow (ttm) | -65527752 USD |
Profile of Q32 Bio Inc.
Country | United Kingdom |
State | MA |
City | Bedford |
Address | One Patriots Park |
ZIP | 01730 |
Phone | 781 301 7277 |
Website | https://www.homologymedicines.com |
Industry | |
Sector(s) | |
Full Time Employees | 92 |
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a nuclease-free gene editing mobility, gene therapy or for various genetic disorders. The company's various set of AAVHSCs allows company to precisely target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, blood-brain-barrier, bone marrow, cardiac and skeletal muscle, and eye. Its lead product candidate is HMI-102, which is in Phase 2 pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; HMI-202 to treat metachromatic leukodystrophy; and HMI-203 for the treatment of mucopolysaccharidosis type II, as well as HMI-104 for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.
Q&A For Q32 Bio Inc. Stock
What is a current 0T6G.L stock price?
Q32 Bio Inc. 0T6G.L stock price today per share is 28.91 USD.
How to purchase Q32 Bio Inc. stock?
You can buy 0T6G.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Q32 Bio Inc.?
The stock symbol or ticker of Q32 Bio Inc. is 0T6G.L.
How many shares does Q32 Bio Inc. have in circulation?
The max supply of Q32 Bio Inc. shares is 384.85K.
What is Q32 Bio Inc. Price to Earnings Ratio (PE Ratio)?
Q32 Bio Inc. PE Ratio is now.
What was Q32 Bio Inc. earnings per share over the trailing 12 months (TTM)?
Q32 Bio Inc. EPS is -0.048 USD over the trailing 12 months.